Recent studies also demonstrate that exposure to a HFD induces hypothalamic as well as peripheral inflammation, 12 and one day of exposure to a HFD (60%) has been shown to be sufficient to increase hypothalamic cytokine expression.
C onverging lines of evidence indicate that hypertension is characterized by increased activity of the renin-angiotensin system (RAS) and elevated levels of proinflammatory cytokines (PICs). The interactions and synergism between the RAS and PICs have been studied in both the periphery and the central nervous system (CNS). We and others have demonstrated that systemic angiotensin (Ang) II administration elicits an increase in blood pressure (BP) that is accompanied by an upregulation of mRNA expression of PICs in the brain. 1, 2 Central injections of PICs, such as tumor necrosis factor (TNF)-α or interleukin (IL)-1β, significantly elevate BP, renal sympathetic nerve activity (RSNA), and brain angiotensin type 1 receptor (AT1-R) and angiotensin-converting enzyme (ACE1) mRNA. 3, 4 Conversely, central inhibition of TNF-α synthesis or blockade of AT1-R significantly reduced the hypertensive effect and diminished the upregulation of mRNA for RAS components and PICs produced by systemic Ang II. 1, 5 Diet-induced obesity in both humans and rodents is associated with an increased prevalence of hypertension. 6 Head et al recently reported that 3 weeks of high-fat diet (HFD) feeding led to increased mean arterial pressure (MAP), heart rate (HR), and RSNA in rabbits. Autonomic ganglion blockade completely abolished the increase in BP, suggesting that this model of obesity-induced hypertension is neurogenic. [7] [8] [9] Obese animals have been shown to have increased RAS activity and elevated levels of Ang II that upregulates AT1-R in a variety of tissues, including the brain. 10, 11 restore body weight (BW), insulin levels, and leptin sensitivity to normal after being switched to normal-fat diet (NFD), BP, RSNA, and the activity of central RAS and PICs remain high 7, 14 These results indicate that obesity itself may induce hypothalamic inflammation and sensitization of the brain to circulating sympathoexcitatory factors, such as those from the RAS, and these initiate increased BP.
Forebrain structures along with the lamina terminalis (LT), including the subfornical organ (SFO), median preoptic nucleus, and organum vasculosum, play important roles in the long-term regulation of BP, body fluid, and energy homeostasis. 15, 16 Our previous work demonstrated that the BP response that manifests as hypertension can be sensitized by treating male rats with mild physiological or dietary challenges at a point earlier in the animal's lifetime. [17] [18] [19] [20] Initial studies found that pretreatment with subpressor doses of either Ang II or aldosterone can upregulate the RAS in the LT and sensitize the hypertensive response to a pressor dose of Ang II 17, 18 and to high dietary salt. 19 Given that brain RAS activation and inflammation are common features of both obesity and hypertension, such results prompted us to hypothesize that exposure to HFD may also sensitize the Ang II-elicited hypertensive response and that the brain RAS and TNF-α signaling may contribute to that response.
Methods

Experimental Protocol
Male Sprague-Dawley rats (10-to 12-weeks old, Harlan, n=131) were used. Rats were prepared with a lateral ventricular cannula, osmotic minipumps for intracerebroventricular (ICV) and subcutaneous drug infusion, and with telemetry probes for continuous BP monitoring, as previously described. 17, 18 The ICV doses of agents used to induce sensitization or to block AT1-R, TNF-α synthesis, or microglial activation were chosen on the basis of published in vivo studies. 3, 17, [21] [22] [23] [24] All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by The University of Iowa Animal Care and Use Committee.
Effects of HFD on Ang II-Induced Hypertension and Molecular Events in the LT
BP was monitored continuously by telemetry in rats that were fed either NFD (10% calories from lard, 3.85 kcal/g, D12450J, Research Diet, NJ) or HFD (60% calories from lard, 5.24 kcal/g, D12492, Research Diet, NJ) for 3 weeks (induction period [I]), followed by NFD for 2 weeks (expression period [E]). During I, rats received ICV vehicle (V), the TNF-α synthesis inhibitor pentoxifylline (PTX, 10 μg/h), the AT1-R blocker irbesartan (Irbe,125 μg/d), or the inhibitor of microglial activation minocycline (Mino, 5 μg/h). These inhibitors were delivered by osmotic pumps (model 2004, 0.25 μL/h for 4 weeks; Alzet) that were disconnected before Ang II infusion. During E, a slow pressor dose of Ang II (120 ng/kg/min) or saline was delivered subcutaneously by osmotic pump (model 2002, 0.5 μL/h for 2 weeks; Alzet). Thus, the primary study groups (n=6/ group) were (1) I-NFD+ICV V+E-Ang II, (2) I-HFD+ICV V+E-saline, (3) I-HFD+ICV V+E-Ang II, (4) I-HFD+ICV PTX+E-Ang II, (5) I-HFD+ICV Irbe+E-Ang II, and (6) I-HFD+ICV Mino+E-Ang II. Three additional HFD groups (n=5/group) received ICV PTX, Irbe, or Mino without Ang II treatment to determine the effect of each of these inhibitors alone on BP throughout I and E periods. Ganglionic blockade by hexamethonium (30 mg/kg IP) was conducted during the baseline period after HFD pretreatment and after 14 days of Ang II infusion. Food consumption, water intake, and BW were measured once a week.
Five treatment groups (n=5/group; I-NFD+ICV V, I-HFD+ICV V, I-HFD+ICV PTX, I-HFD+ICV Irbe, and I-HFD+ICV Mino) were euthanized after I but before E for molecular studies to determine the effect of HFD and inhibitors on mRNA expression of RAS and inflammatory elements in the structures lying along the LT (ie, the SFO, median preoptic nucleus, and organum vasculosum).
Effects of Brain RAS and Inflammation on Ang II-Induced Hypertension and Molecular Events in the LT
Rats were fed normal rat chow (7013 NIH-31 modified rat diet) ad libitum. BP was monitored continuously during an induction-delayexpression (I-D-E) protocol, as described previously. 
Additional Methods
Please see the online-only Data Supplement. The hexamethonium-induced decreases in MAP were comparable in all groups before HFD treatment (averaged −21.6±0.6 mm Hg; Figure 1C ). HFD alone or HFD combined with central inhibition of TNF-α synthesis, AT1-R, or microglial activation also had no effect on the decrease in MAP produced by acute ganglionic blockade (averaged −23.8±1.4 mm Hg; Figure 1C ). However, after 14 days of Ang II infusion, acute hexamethonium injection resulted in significant Figure 2C ). During E, with all groups receiving the NFD and the Ang II infusion, caloric intake was comparable in rats that had been induced with NFD or HFD (P>0.05), and the rates of BW gain were significantly reduced in all groups (P<0.05, Figure 2C ).
Results
HFD-Induced Sensitization of Ang II Hypertension
Effect of ICV PTX, Irbe, or Mino on HFD-Induced mRNA Expression of RAS and Inflammatory Elements in the LT
In LT tissue collected at the end of HFD feeding, HFD induced a significant increase in the mRNA expression of the inflammatory elements (ie, TNF-α, IL-6, the microglial marker CD11b) and some (ie, renin, AT1-R, ACE1), but not all, RAS components in the LT when compared with controls (P<0.05). The expression of angiotensinogen (AGT), mineralocorticoid receptor, NADPH oxidase 2, and IL-1β in the LT was not affected by HFD (P>0.05, Figure 3A and 3B).
Central infusion of PTX, Irbe, or Mino normalized the increased mRNA expression of renin, TNF-α, IL-6, and CD11b produced by HFD (P<0.05, Figure 3A and 3B). Among the RAS components whose expression was upregulated by HFD, the increased AT1-R expression was attenuated by ICV PTX, the elevated expression of AGT and ACE1 were inhibited by ICV Irbe, whereas the increased expression of AGT and AT1-R was attenuated by ICV Mino (P<0.05; Figure 3A and 3B). Message for mineralocorticoid receptor, NADPH oxidase 2, and IL-1β remained unchanged.
ICV TNF-α-and Low-Dose Ang II-Induced Sensitization of Ang II Hypertension
To confirm the direct sensitizing actions of central TNF-α and its mediation of central Ang II-induced sensitization, TNF-α, or a supressor dose of Ang II combined with either a TNF-α synthesis inhibitor or an inhibitor of microglial activation was infused ICV for 1 week during I. These treatments had no effect on MAP during I ( Figure 4A 
Effect of ICV PTX or Mino on Central Subpressor Dose of Ang II-Induced mRNA Expression of RAS Components, PICs, and Microglial Marker in the LT
In LT tissue collected at the end of D period, the ICV subpressor dose of Ang II given during I produced a significant increase in the mRNA expression of renin, AGT, AT1-R, ACE1, mineralocorticoid receptor, NADPH oxidase 2, TNF-α, IL-6, and CD11b (P<0.05), but had no effect on the mRNA expression of IL-1β when compared with controls. The ICV infusion of TNF-α during I similarly elicited most of the increases in the mRNA expression induced by Ang II except the mRNA expression of AGT, mineralocorticoid receptor, TNF-α, but had a significant potentiating effect on the Figure 5A and 5B).
Discussion
Obesity-related hypertension is a major risk factor for the development of cardiovascular diseases. These studies provide evidence that a short-term exposure to HFD activates the RAS and PICs in the LT and sensitizes the pressor actions of Ang II. A similar sensitization of the Ang II-induced hypertensive response can be produced by ICV administration of TNF-α or a subpressor dose of Ang II. These observations indicate that activation of the RAS and PICs and the interaction between these 2 systems are involved in the process of sensitization. The sensitizing action of HFD is also associated with activation of microglia, which express AT1-R and PIC receptors and are a potential source of PICs. 24, 25 Taken together, these results suggest that eating a HFD for a short time can induce remarkable changes in CNS function that increase the vulnerability to hypertension.
Overproduction of Ang II or excessive activation of the brain RAS contributes to the genesis of cardiovascular diseases, including hypertension. 26 Ang II can act as a potent proinflammatory agent and stimulate the production of PICs, such as TNF-α, IL-6, and IL-1β in the brain that augment hypertensive responses. 1, 24, 27 The possible cellular sources of brain PICs include CD11b+ microglia and neurons. 25 A recent study demonstrated that inflammation and microglial activation within the hypothalamic paraventricular nucleus are associated with elevated BP and augmented sympathetic activity induced by Ang II infusion. 24 Furthermore, ICV TNF-α injection elevates BP and sympathetic activity in a dose-dependent manner. 4 PICs act within the SFO to upregulate the expression of components of the RAS and mediators of inflammation that elicit a sympathoexcitatory response mediated by the RAS. 3 Central inhibition of TNF-α reverses alterations in RAS components and attenuates Ang II-induced hypertension. 1 Moreover, both Ang II and TNF-α can activate NADPH oxidase, leading to enhanced oxidative stress and decreased bioavailability of NO that combine to contribute to increases in SNA and BP. 26 These studies confirm that the brain RAS and PICs can mutually facilitate each other's expression in the CNS, as well as the sympathoexcitatory and pressor effects that generate hypertension.
1,2 Previous studies from our laboratory have shown that subpressor doses of Ang II and aldosterone given during I produced upregulation of components of the brain RAS, resulting in a sensitized hypertensive response to a subsequently administered, pressor dose of Ang II. 17, 18 The present study extends our previous work by showing that central pretreatment with TNF-α mimicked the sensitizing actions of Ang II, upregulating mRNA expression of the RAS components, PICs, microglial marker, and NADPH oxidase in the LT and augmenting the hypertensive response to a pressor dose of Ang II. Inhibition of either TNF-α synthesis or microglia activation abolished these changes. These results indicate that Ang II upregulation of PICs and microglial activation mediate Ang II-induced sensitization and suggest that low-grade central inflammation induced by different classes of stimuli can sensitize the brain to be predisposed to the expression of frank hypertension.
The RAS and PICs have both been implicated in the regulation of energy balance and obesity-induced hypertension. Not only does adipose tissue have a local RAS, 12,28 but serum levels of major components of the RAS (renin, AGT, ACE) are elevated in obesity. 10 TNF-α is commonly considered as one of the initiators of the proinflammatory cascade, which can induce the production of other cytokines. Inhibition of TNF-α during inflammatory events abolishes many of the ensuing responses, including increased IL-1β and IL-6. 29 TNF-α levels are increased in obesity and serve as a marker for obesity. 30 Recent studies have revealed that HFD feeding increases hypothalamic PIC expression, including IL-1β, IL-6, and TNF-α, and several components of the RAS, such as AT1-R. 14, 31 The increased gene expression for the RAS and for PICs is accompanied by increased microglial activation in the hypothalamus, including the arcuate nucleus, SFO, and hypothalamic paraventricular nucleus. 13, 32, 33 Some of these responses were reversed on deletion of AT1a specially within the hypothalamic paraventricular nucleus. 31 It has been shown that systemic RAS and TNF-α, which are both increased in obesity, play a role in promoting energy storage, whereas these 2 systems act within the CNS to increase energy expenditure. 11, 34, 35 The difference between the central and peripheral effects of the RAS and TNF-α suggests the presence of a negative feedback mechanism that is activated when peripheral RAS activity and TNF-α levels are high and gain access to the brain. 11 However, this putative central negative feedback pathway for energy balance triggers the cardiovascular consequences of activation of the RAS and PICs with resultant elevations of SNA and BP. Consistent with the activating effect of obesity on the brain, we found in the present study that the HFD feeding significantly elicited increases in mRNA expression of several RAS components, PICs, and a microglial marker in the LT. These changes might reflect a mechanism for sensitizing the brain cardiovascular nuclei and enhance their reactivity, which is evident by the enhanced hypertensive response to the subsequent Ang II infusion in the HFD-fed rats. Furthermore, central inhibition of AT1-R and inflammation during HFD feeding abolished the HFD-induced sensitizing effect on hypertension. Combined with the findings that a low dose of TNFα or Ang II administered centrally directly sensitizes Ang II-induced hypertension, these observations suggest that the HFD-induced upregulation of the RAS and PICs in the CNS participates in the sensitization process. The capacity of the RAS or PICs to mutually upregulate their expression may be indicative of actions within central sensitization-related positive feedforward systems, which can accelerate the onset and rate of development of hypertension.
It should be noted that many previous studies have used long-term HFD feeding (8 weeks or more longer time) to produce obesity and elevated levels of RAS components and of PICs (eg, TNF-α) in both brain and peripheral tissues. 11, 14, 31, 34 However, one recent study showed that in rats predisposed to diet-induced obesity, the expression of proinflammatory biomarkers was increased in the mediobasal hypothalamus within 24 h of HFD onset, 13 suggesting that hypothalamic inflammation occurs before obesity onset. This raises questions as to what factor(s) or through which pathway HFD activates the CNS RAS and inflammation so that the brain is sensitized to circulating hypertensive agents in the initial stages of overnutrition before the advent of increased systemic inflammation and RAS activation.
It has been shown that the hypothalamic structures residing inside blood-brain barrier, including the arcuate nucleus, hypothalamic paraventricular nucleus, supraoptic nucleus, and lateral hypothalamus, are major sites for the regulation of autonomic and energy processes. 4, 11, 36 The LT, including the SFO, a sensory circumventricular organ lacking the normal blood-brain barrier, has also been documented as a CNS structure involved in both cardiovascular regulation and energy homeostasis. 16, 37 The SFO sends efferent projections to communicate with these hypothalamic nuclei inside bloodbrain barrier. 16 In the present study, we found that 3 weeks of HFD feeding significantly increased the mRNA expression of the RAS and PICs in the LT. This result suggests that the components of the LT may first sense factors produced by HFD feeding and respond to the changes in the energy homeostasis by producing increased activation of the RAS and PICs in the cardiovascular neural network without apparent changes in the BP and sympathetic activity. Further study is needed to investigate the hypothalamic nuclei involving the HFDinduced sensitization process, as well as looking more specifically at the pathway between the SFO and the hypothalamic nuclei involved in processing signals associated with the RAS and PICs that are initiated in the course of developing obesity.
Recently, a series of studies from Head et al demonstrated in rabbits that 3 weeks of HFD feeding rapidly produced increased MAP, HR, and RSNA. [6] [7] [8] This obesityinduced hypertension could be blocked by a central leptin antagonist after 3 weeks of HFD, which is a time when BW, visceral white adipose tissue, and plasma leptin levels were markedly elevated. 38 They also found that the hypertension and high RSNA persisted long after stopping HFD and the normalization of circulating levels of leptin. These findings raise the possibility that HFD produces factors in addition to leptin that contribute to the increases in BP and SNA. It is likely that these other factors are the RAS components and PICs. 39, 40 Results of the current study showing that 3 weeks of HFD feeding significantly increased BW and the mRNA expression of the RAS and PICs in the LT point to these as additional important mediating factors. Combining the results of the Head et al studies [6] [7] [8] with the current findings, it can be hypothesized that either local or systemic RAS components and PICs, probably stimulated by the HFD itself or by leptin, 41 are the critical mediators of HFD-induced sensitization of hypertension.
Because mRNA gene expression results do not always reflect protein expression or activity levels, one limitation of the present study is that we did not determine activity and protein levels of the RAS components and PICs as the basis of the changes in the mRNA levels after HFD treatment.
Therefore, further studies to analyze the protein levels in cardiovascular nuclei and circulating concentrations of the RAS and PICs after short-term HFD may uncover mechanisms through which the HFD modulates the brain nuclei sensitivity that participates in the pathophysiology of obesity-related hypertension. Another limitation is that the TNF-α synthesis inhibitor PTX and the inhibitor of microglial activation Mino used in the present study are not selective and affect multiple biochemical targets. 42, 43 However, using both PTX and Mino produced results that converge to be highly suggestive that inflammation and related factors are involved in mediating the sensitizing effects of HFD on the hypertensive response. The use of more selective inhibitors in the future studies should lend additional support to this interpretation of our current findings.
Perspectives
Clinical and experimental data indicate important interactions between obesity and hypertension. Activation of both the RAS and PICs in the CNS play a critical role in the development of obesity, hypertension, or both. The present findings indicate that similar to the sensitizing effects of subpressor doses of Ang II or aldosterone, 17, 18 sensitization by HFD feeding is associated with maintained changes in the expression of pressor components of the brain RAS and PICs. These observations provide novel evidence and insight for the actions of RAS and of PICs on LT structures to mediate cardiovascular sensitizing effects of metabolic factors, even though these factors do not induce immediate abnormalities in the cardiovascular function. One implication of these and our demonstrations of sensitization and maintained neuroplasticity [17] [18] [19] [20] is that challenges to homeostasis can act to reprogram the neural network controlling BP to generate an enhanced pressor response when a hypertensinogenic stimulus is either sustained or encountered at a later time. 
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